Origin Agritech Limited (SEED)
NASDAQ:SEED
Want to see SEED full AI Analyst Report?
SEED Stock Chart & Stats
$1.32
-$0.10(-5.19%)
At close: 4:00 PM EST
$1.32
-$0.10(-5.19%)
Day’s Range― - ―
52-Week Range$0.74 - $2.49
Previous CloseN/A
Volume43.60K
Average Volume (3M)2.25M
Market Cap
$13.72M
Enterprise Value$90.41M
Total Cash (Recent Filing)$15.91M
Total Debt (Recent Filing)$54.27M
Price to Earnings (P/E)―
Beta0.56
Next Earnings
Jan 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.09
Shares Outstanding12,143,526
10 Day Avg. Volume6,011,928
30 Day Avg. Volume2,246,586
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-2.76
Price to Sales (P/S)0.72
P/FCF Ratio-1.80
Enterprise Value/Market Cap6.59
Enterprise Value/Revenue1.21
Enterprise Value/Gross Profit11.50
Enterprise Value/Ebitda-3.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Deep Breeding & R&D PipelineOrigin's scale of breeding activity, large combinatorial test program and AI‑enabled access to 200k+ germplasm create a durable discovery engine. A deep pipeline increases the probability of commercially viable varieties and licensing opportunities over multi-year horizons.
Biotech Credentials & ReadinessPossession of biosafety certification, production licenses and a restored processing facility materially shortens regulatory and operational hurdles for commercialization. The Marker Consortium and biotech toolset support diversified monetization (traits, services) beyond seed sales long-term.
Rebuilt Commercial CapabilityA targeted sales rebuild and the Aoyun regional program create durable route‑to‑market capacity for new corn varieties. Scaled field presence and KPI contracts reduce go‑to‑market friction and improve odds that R&D output converts into sustained regional revenue over coming seasons.
Bears Say
Stressed Balance SheetNegative equity and a material increase in debt in 2025 limit financial flexibility and raise refinancing and dilution risk. A fragile capital structure constrains the company's ability to absorb execution setbacks or fund multi-year breeding commercialization without external capital.
Weak Cash GenerationPersistent operating cash burn and negative free cash flow mean the business does not self‑fund growth. Over 2–6 months this raises reliance on financing, increases vulnerability to higher borrowing costs, and can impede timely commercialization investments and inventory management.
Regulatory & Execution DependencyMaterial upside is tied to regulatory approvals for GMO products and the company's ability to translate pipeline and sales investments into marketable varieties. Regulatory timing uncertainty plus the need to deliver commercial traction creates multiyear execution risk to revenue realization.
Origin Agritech News
SEED FAQ
What was Origin Agritech Limited’s price range in the past 12 months?
Origin Agritech Limited lowest stock price was $0.74 and its highest was $2.49 in the past 12 months.
What is Origin Agritech Limited’s market cap?
Origin Agritech Limited’s market cap is $13.72M.
When is Origin Agritech Limited’s upcoming earnings report date?
Origin Agritech Limited’s upcoming earnings report date is Jan 11, 2027 which is in 222 days.
How were Origin Agritech Limited’s earnings last quarter?
Origin Agritech Limited released its earnings results on May 21, 2026. The company reported -$0.172 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.172.
Is Origin Agritech Limited overvalued?
According to Wall Street analysts Origin Agritech Limited’s price is currently Overvalued.
Does Origin Agritech Limited pay dividends?
Origin Agritech Limited does not currently pay dividends.
What is Origin Agritech Limited’s EPS estimate?
Origin Agritech Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Origin Agritech Limited have?
Origin Agritech Limited has 12,143,526 shares outstanding.
What happened to Origin Agritech Limited’s price movement after its last earnings report?
Origin Agritech Limited reported an EPS of -$0.172 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Origin Agritech Limited?
Currently, no hedge funds are holding shares in SEED
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Origin Agritech Limited
Origin Agritech Limited, together with its subsidiaries, operates an agricultural biotechnology and an e-commerce platform in the People's Republic of China. The company engages in crop seed breeding and genetic improvement activities. It develops, produces, and distributes hybrid crop seeds, as well as develops hybrid seed technology. The company also operates an e-commerce platform, which provides range of products, including agricultural seed products that comprise corn, rice, and vegetable seeds; other agricultural inputs, such as fertilizers and agricultural chemicals; foods; household products; and other consumer products to farmers through online and mobile ordering. It has a collaboration agreement with Chinese Academy of Agricultural Sciences, the National Maize Improvement Center, China Agricultural University, and Zhejiang University. Origin Agritech Limited was founded in 1997 and is headquartered in Beijing, China.
SEED Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced view: clear operational and structural progress (large cuts in G&A, improved operating loss, strengthened biotech credentials, rebuilt sales force, sizable breeding pipeline and targeted variety acquisitions) alongside meaningful near-term challenges (a 31.9% revenue decline, ongoing net loss, modest cash position, higher inventories and dependency on regulatory timing for GMO commercialization). Management emphasized that the company is in the midpoint of a recovery plan and investing in sales and R&D to convert pipeline into revenue, but realization of that upside remains contingent on execution and policy developments.View all SEED earnings summariesTechnical Analysis
American Vanguard
―
Arcadia Biosciences
―
BioHarvest Sciences
―
Bioceres Crop Solutions
―
―
Ownership Overview
―
Insiders
0.07% Mutual Funds
0.33% Other Institutional Investors
99.60% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---